Download presentation
Presentation is loading. Please wait.
Published byMarian Joseph Modified over 9 years ago
1
Varicella vaccine should be introduced into the UK immunisation programme immediately Andrew J Pollard
2
Varicella The vaccine programme is about improving child health Burden of disease Mortality Complications
3
Chickenpox Epidemiology 90% infected by 18 years of age 670,000 cases per year in England & Wales 51% of cases <5 years of age 84% of cases <15 (~600,000) 14% in 15-44 year age group = 100,000 cases
4
Extrapolation from German data Varicella-related hospitalization 14.1/100,000 children (95% CI: 9.7–18.6), 27 hospitalizations per 10,000 varicella cases. 1809 children hospitalised per year 6 deaths per year
5
Transmission 90% of non-immune household contacts become infected Any face to face contact 15 minutes in the same room Any ward exposure Options –VZIG –Active vaccination –Anti-virals
6
Complications BPSU Nov 2002-Nov 2003 –112 cases 30 pneumonia 30 bacteraemia/septic shock 26 encephalitis 25 ataxia 14 toxic shock 7 necrotising fasciitis 5 purpura fulminans 5 fulminant varicella 3 neonatal varicella 29 admitted to icu 6 deaths Cameron at al 2007
7
Complications Blood 69% Group A Strep 12% Staph aureus Skin 36% Group A Strep 64% Staph aureus Cameron at al 2007
8
Pregnancy 5-10% childbearing age are susceptible Tropical areas may be as high as 20-40% Infection in first 20 weeks = 1-2 % congenital varicella
9
Vaccine Efficacy 5 years = 90% 97% effective against severe and moderately severe disease Breakthrough cases 5-7% over 5 years 2 nd dose of VZV 5-107 spots Mixture of maculopapular and vesicles Shinefield 2002, Vazquez 2001, Chaves 2007
10
Adverse events Varicella rash –4-6% –Day 2-33 –Number of spots 1-100 –Duration of spots 1-16 White 1991, Lau 2002
11
Oxman 2005 ZOSTER
12
Impact of varicella vaccine Decline in mortality in USA Nguyen 2005 Vaccine introduced in 1995
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.